A vaccine candidate for HIV steps into phase III trials, signs emerge that antibiotics impair vaccine performance, and other highlights from clinical trials and laboratory studies.
Outbreaks of some viral infections, including measles and hepatitis A, are increasing across the country.
The experimental vaccine targets virus strains from around the world.
Johnson & Johnson is preparing to test an experimental HIV vaccine in the U.S. and Europe in a move toward developing the first immunization against the deadly disease after decades of frustration.
Johnson & Johnson is preparing to test an experimental HIV vaccine in the United States and Europe in a move toward developing the first immunization against the deadly disease after decades of frustration. Read Article
Dr. Dan Barouch accepts the Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019 in Washington D.C., on April 15th 2019
Dr.Barouch spoke to Discover Magazine about a promising candidate for an HIV vaccine raises hopes. Read Article
Scientific investigation into the world’s second man cleared of the AIDS virus is zooming in on a gene and a treatment side-effect, as newly-enthused researchers strive to find a cure for the disease that has killed millions.
Dr. Dan Barouch discusses the challenges in designing an HIV vaccine and the ongoing clinical trials with vaccine research at BIDMC.
“We are optimistic that an end to the HIV pandemic is feasible. However, to reach this goal, we must apply the tools and advances already at hand as we continue to follow the science in laboratories and clinics around the world. Today we honor the achievements of dedicated researchers, health care professionals, clinical trial participants and members of the global community, and we reaffirm our commitment to work together to fill the remaining gaps. [NIH news]
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
E/CLS 10th floor
Boston, MA 02115 – USA
CVVR Clinical Trials Unit